Ra Pharmaceuticals Inc Asset Turnover Ratio (RARX), as of fourth quarter 2019, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Ra Pharmaceuticals Inc   (RARX)
 

Ra Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Ra Pharmaceuticals Inc asset turnover ratio, the ability of Ra Pharmaceuticals Inc 's assets to generate revenue in the fourth quarter 2019, increased sequentially to 0.03 in the fourth quarter (Dec 31 2019), RARX's balance sheet remain strong.

Within sector Ra Pharmaceuticals Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the fourth quarter 2019 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RARX Asset Turnover Ratio (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter
Y / Y Asset Change 28.98 % 240.92 % 79.31 % 73.53 % 173.35 %
Y / Y Revenue Change 72.56 % - - - -
Asset Turnover Ratio (TTM) 0.03 0.02 - - 0.02
RARX's Total Ranking # # # # #
Seq. Asset Change -8.47 % 63.25 % -7.72 % -6.46 % 141.91 %
Seq. Revenue Change 43.8 % - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




RARX Company Profile • Back to RARX Efficiency Comparisons • Compare RARX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2019, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2019 Assets at quarter ending Dec 31 2019
Vivosim Labs Inc   0.07 $ 2.876  Millions$ 40.617  Millions
Regenxbio Inc   0.07 $ 35.233  Millions$ 513.829  Millions
Purple Biotech Ltd  0.07 $ 1.000  Millions$ 14.718  Millions
Cue Biopharma Inc   0.07 $ 3.458  Millions$ 50.940  Millions
Chinook Therapeutics Inc   0.07 $ 17.258  Millions$ 255.653  Millions
Reata Pharmaceuticals Inc   0.07 $ 26.517  Millions$ 393.329  Millions
Sintx Technologies Inc   0.07 $ 0.689  Millions$ 10.320  Millions
Biocorrx Inc   0.07 $ 0.240  Millions$ 3.605  Millions
Arcus Biosciences Inc   0.07 $ 15.000  Millions$ 229.393  Millions
Paratek Pharmaceuticals Inc   0.06 $ 16.544  Millions$ 263.219  Millions
Epizyme Inc.  0.06 $ 23.800  Millions$ 385.730  Millions
Accelerate Diagnostics Inc   0.06 $ 9.297  Millions$ 153.133  Millions
Assembly Biosciences Inc   0.06 $ 15.963  Millions$ 266.003  Millions
Vaccinex Inc   0.06 $ 0.523  Millions$ 8.957  Millions
Asensus Surgical Inc   0.06 $ 8.531  Millions$ 148.192  Millions
Dicerna Pharmaceuticals Inc   0.06 $ 23.904  Millions$ 419.761  Millions
Nektar Therapeutics  0.06 $ 114.617  Millions$ 2,082.946  Millions
Five Prime Therapeutics Inc   0.05 $ 14.874  Millions$ 272.839  Millions
Sorrento Therapeutics Inc   0.05 $ 31.432  Millions$ 578.756  Millions
Albireo Pharma inc   0.05 $ 9.636  Millions$ 177.971  Millions
Ibio inc   0.05 $ 1.744  Millions$ 33.003  Millions
Lite Strategy Inc   0.05 $ 4.543  Millions$ 86.154  Millions
Intelgenx Technologies Corp   0.05 $ 0.742  Millions$ 14.556  Millions
Editas Medicine Inc   0.05 $ 20.531  Millions$ 403.946  Millions
Generex Biotechnology Corp  0.05 $ 2.621  Millions$ 52.004  Millions
Electrocore Inc   0.05 $ 2.390  Millions$ 48.150  Millions
Co diagnostics Inc   0.05 $ 0.215  Millions$ 4.367  Millions
Argenx Se  0.05 $ 78.462  Millions$ 1,610.215  Millions
Infinity Pharmaceuticals Inc   0.05 $ 3.049  Millions$ 62.826  Millions
Arbutus Biopharma Corp  0.05 $ 6.011  Millions$ 124.448  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.